Pioneering the Future of Cancer Immunotherapy

Extended tumor cell targeting

Close-up of T cells interacting with cancer cells under a microscope

Close-up of T cells interacting with cancer cells under a microscope

A revolutionary approach that harnesses the power of your immune system to fight cancer

Our Objective

Animus BioPharma is transforming lives through revolutionary ARM T-cell technology. Activating immune cells to fight cancer with unprecedented precision and efficacy.

Our Approach

Animus BioPharma combines reactivation of the immune killer T-cells to specifically target cancer cells while sparing healthy cells. This approach is achieved through deep immunological expertise that creates generalized but directed cancer treatments that work with your body's natural defenses.

Our Services

Pioneering T-cell therapies targeting cancers with precision and care.

Therapeutic Licensing

Close-up of scientists collaborating over molecular models in a bright lab.

Close-up of scientists collaborating over molecular models in a bright lab.

License our arm T-cell technology to develop new cancer treatments.

Dynamic visualization of T-cells targeting tumor cells in the body.

Dynamic visualization of T-cells targeting tumor cells in the body.

Experienced management team discussing strategy in a modern office.

Experienced management team discussing strategy in a modern office.

Co-Development

Partner with us to co-create next-gen immunotherapies for diverse patients.

Expert guidance from our seasoned leadership to support your projects.

Strategic Support

Stay Informed

Get updates on our latest breakthroughs